InvestorsHub Logo
Followers 91
Posts 4306
Boards Moderated 1
Alias Born 01/19/2014

Re: boston127 post# 6769

Friday, 06/30/2017 5:11:24 PM

Friday, June 30, 2017 5:11:24 PM

Post# of 21373
This is still a speculative stock, but the Clemson professor behind Prolanta has a history of success. And...with the backing off Komen Foundation, who knows how high Oncolix will climb. I think once fully approved, $30 is not unreasonable, but that is years away.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.